Comment
doi: 10.1016/S0140-6736(11)61254-3.
Epub 2011 Nov 3.
High-risk prostate cancer: treat the prostate
Affiliations
- PMID: 22056154
- DOI: 10.1016/S0140-6736(11)61254-3
Item in Clipboard
Comment
High-risk prostate cancer: treat the prostate
Lancet.
.
No abstract available
Comment on
-
Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.Lancet. 2011 Dec 17;378(9809):2104-11. doi: 10.1016/S0140-6736(11)61095-7. Epub 2011 Nov 2. Lancet. 2011. PMID: 22056152 Free PMC article. Clinical Trial.
Similar articles
-
Hormonal management of advanced adenocarcinoma of the prostate.Henry Ford Hosp Med J. 1989;37(1):16-8. Henry Ford Hosp Med J. 1989. PMID: 2670839 No abstract available.
-
[Complete hormonal block vs. simple hormonal block in the treatment of carcinoma of the prostate].Arch Esp Urol. 2002 Sep;55(7):771-5. Arch Esp Urol. 2002. PMID: 12380304 Spanish. No abstract available.
-
Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).Cancer. 2006 Apr 15;106(8):1708-14. doi: 10.1002/cncr.21799. Cancer. 2006. PMID: 16544313
-
What to do if prostate cancer returns.Johns Hopkins Med Lett Health After 50. 2001 Dec;13(10):6-7. Johns Hopkins Med Lett Health After 50. 2001. PMID: 11727445 Review. No abstract available.
-
[Total androgen blockade therapy].Nihon Rinsho. 2000 Jul;58 Suppl:197-201. Nihon Rinsho. 2000. PMID: 11022713 Review. Japanese. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
